BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 38547865)

  • 1. Microbiome bacterial influencers of host immunity and response to immunotherapy.
    Yousefi Y; Baines KJ; Maleki Vareki S
    Cell Rep Med; 2024 Apr; 5(4):101487. PubMed ID: 38547865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
    Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
    J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota and immunotherapy of renal cell carcinoma.
    Bibbò S; Porcari S; Del Vecchio LE; Severino A; Mullish BH; Ianiro G; Gasbarrini A; Cammarota G
    Hum Vaccin Immunother; 2023 Dec; 19(3):2268982. PubMed ID: 37955340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
    Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
    Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.
    Hayase E; Jenq RR
    Genome Med; 2021 Jun; 13(1):107. PubMed ID: 34162429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
    Zhao H; Wang D; Zhang Z; Xian J; Bai X
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.
    Zhang J; Dai Z; Yan C; Zhang W; Wang D; Tang D
    Clin Transl Oncol; 2021 Dec; 23(12):2415-2430. PubMed ID: 34125407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Applications of the Gut Microbiome in Genitourinary Cancers.
    Nguyen CB; Vaishampayan UN
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e100041. PubMed ID: 38788173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer.
    Duttagupta S; Hakozaki T; Routy B; Messaoudene M
    Curr Oncol; 2023 Oct; 30(11):9406-9427. PubMed ID: 37999101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The triple interactions between gut microbiota, mycobiota and host immunity.
    Yang J; Yang H; Li Y
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):11604-11624. PubMed ID: 35776086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure.
    Velikova T; Krastev B; Lozenov S; Gencheva R; Peshevska-Sekulovska M; Nikolaev G; Peruhova M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review).
    Jiang H; Zhang Q
    Oncol Lett; 2024 Feb; 27(2):87. PubMed ID: 38249807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the gut microbiome for cancer patients receiving immunotherapy: Dietary and treatment implications.
    Lee KA; Shaw HM; Bataille V; Nathan P; Spector TD
    Eur J Cancer; 2020 Oct; 138():149-155. PubMed ID: 32889369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
    Ting NL; Lau HC; Yu J
    Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
    Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
    Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.